Takeaways from Industry Experts: Building a Strategic Commercialization Plan for Rare Disease Therapies
Commercializing a therapy for rare diseases is a challenging endeavor. With the complexities of patient access, regulatory hurdles, and stakeholder engagement, manufacturers must adopt a carefully crafted strategic framework. In a recent Access USA panel discussion, industry experts shared their valuable perspectives on this topic. The panel featured Justin Bush from Pharavis, Richard Wilson from […]